Stale Pre-tender

Provisions of an Oesophageal Cell Collection Device (OCCD) and service delivery to pathology lab, pathology service and pathology reporting to NHS Scotland

Details

Value
GBP 700,000
Topic
Pathology services
Published
7 February 2024

Tender description

This requirement is for an Oesophageal Cell Collection Device (OCCD) diagnostic service inclusive of delivery of pathology lab test to initiating clinician, which must be able to be integrated into the NHS, across Scotland with the aim of improving the patient journey, improving outcomes and reducing the requirement for traditional hospital-based procedures. As outlined above, Supplier must be able to provide holistic service of an Oesophageal Cell Collection Device (OCCD) and diagnostic service inclusive of delivery of pathology lab test.

Timeline

  1. Completed: Pre-tender published7 February 2024
    Current notice

About the buyer

NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 85111800 · Pathology services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

7 similar open tenders

See more open tenders related to Provisions of an Oesophageal Cell Collection Device (OCCD) and service delivery to pathology lab, pathology service and pathology reporting to NHS Scotland.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.